Revenue
2019
2020
2021
2022
2023
2024
2025
Caribou Biosciences, Inc. (CRBU)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $11.2M | $10.0M | $34.5M | $13.9M | $9.6M | $12.4M | $5.8M |
| Research & development | $109.4M | $130.2M | $112.1M | $82.2M | $52.3M | $34.4M | $23.6M |
| Operating expenses | $159.5M | $176.6M | $150.5M | $120.3M | $76.6M | $48.5M | $40.1M |
| Operating income | −$148.3M | −$166.6M | −$116.1M | −$106.4M | −$67.0M | −$36.1M | −$34.3M |
| EBITDAderived | −$144.7M | −$162.7M | −$112.5M | −$104.8M | −$66.0M | −$35.2M | −$33.6M |
| Net income | −$148.1M | −$149.1M | −$102.1M | −$99.4M | −$66.9M | −$34.3M | −$23.4M |
| Basic EPSper diluted share | -$1.59 | -$1.65 | -$1.38 | -$1.64 | -$2.11 | -$4.01 | -$2.80 |
| Diluted EPSper diluted share | -$1.59 | -$1.65 | -$1.38 | -$1.64 | -$2.11 | -$4.01 | -$2.80 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 25, 2026Form 4 | Kelly Timothy PChief Technology Officer | SellCommon Stock | 6.2K | $1.93 | $12.0K | 73.1K |
| Feb 24, 2026Form 4 · 10b5-1 | Albertson Tina M.Chief Medical Officer | SellCommon Stock | 1.1K | $1.96 | $2.1K | 68.5K |
| Feb 24, 2026Form 4 | Khan Ruhi AhmadChief Business Officer | SellCommon Stock | 6.9K | $1.96 | $13.6K | 105.0K |
| Feb 24, 2026Form 4 | Kelly Timothy PChief Technology Officer | SellCommon Stock | 3.1K | $1.96 | $6.2K | 79.4K |
| Feb 24, 2026Form 4 | MCCLUNG BARBARA GChief Legal Officer | SellCommon Stock | 6.9K | $1.96 | $13.6K | 481.6K |